U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07699107) titled 'Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial' on July 07.
Brief Summary: The goal of this clinical trial is to learn whether children and young adults with well-controlled juvenile idiopathic arthritis (JIA)-associated uveitis or chronic anterior uveitis can safely take adalimumab (or biosimilar) injections less often while maintaining control of their disease.
The main question it aims to answer is: can adalimumab/biosimilar injections be given less frequently without uveitis (eye inflammation) or arthritis (joint inflammation) returning?
Researchers will compare adalimumab/biosimilar injection schedules of ev...